Text size :

Marra (Diabetes Italy): “Ensure equitable care and homogeneous pathways across the territory”

ADNKRONOS

November 10, 2026

Rome, 10 Nov. (Adnkronos Health) – “Among the main interventions that would be necessary to implement today to prevent patients with diabetes from continuing to encounter critical issues, there is, first and foremost, the guarantee of equity in access to care. With the current organization of regional healthcare that we have in Italy, unfortunately, there are great differences in the capacity of regional institutions to apply homogeneous pathways throughout the national territory.” This was stated by Fabiano Marra, president of Diabetes Italy, speaking at the meeting promoted today in Rome by Senator Francesco Zaffini in view of World Diabetes Day. Titled ‘Diabetes Today: Perspectives and Challenges’, the discussion held in the Senate brought together institutions, the scientific community, healthcare professionals, patient associations, and health system stakeholders.

“This, unfortunately, is determined by the inability, in some cases, to correctly allocate resources for health and, in others, probably, by a lack of sensitivity towards prevention, which could translate into savings – he explains – because, today, the main expenditure for diabetes is already very high: the pathology, in fact, absorbs about 15% of national healthcare spending, and, of this share, over 50% is represented by the costs of complications due to an incorrect treatment pathway.” “If administrators had the ability to have a medium-to-long-term vision, all these healthcare expenses could be saved in favor of prevention that allows patients, on the one hand, to access care equitably in all regions, and, on the other hand, to avoid complications that represent the main expenditure in the diabetological field.”

“The quality of life for a person with diabetes does not consist of controlling glycated hemoglobin, which is the blood sugar value referred to the last three months, because this data could be falsified by a not particularly correct management of the pathology – Marra emphasized – Quality of life means, instead, not having glycemic fluctuations; being aware of what it means to live with this disease and having technological tools that facilitate its management. Technology must be accessible to everyone: even those who are not very familiar with it should be able to use it easily. This means that all the possibilities offered by technology, from data transmission to constant monitoring and control of the situation, should be automated within these systems, which should therefore be simpler for everyone to use. Another important aspect, in addition to technology, is access to new innovative drugs, which allow diabetes to be treated more simply and ensure that the complications we have seen until today do not occur. The new available drugs are not always accessible to everyone, due to the different ways in which various regions allow people with diabetes to access them.”

Jiji Press

Related

Page TOP